Melting Point Distribution Analysis of Globally Approved and Discontinued Drugs: A Research for Improving the Chance of Success of Drug Design and Discovery
The melting point (MP), an easily accessible physical parameter, has considerable potential for the judgment of drug‐like properties. However, to the best of our knowledge, there are no useful guidelines for understanding the relationship between the MP and drug‐like properties. To this end, we have...
Main Authors: | Mao, Fei, Kong, Qingya, Ni, Wei, Xu, Xiang, Ling, Dazheng, Lu, Zhengyu, Li, Jian |
---|---|
Format: | Online |
Language: | English |
Published: |
John Wiley and Sons Inc.
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4981057/ |
Similar Items
-
Zika antiviral chemotherapy: identification of drugs and promising starting points for drug discovery from an FDA-approved library
by: Pascoalino, Bruno S., et al.
Published: (2016) -
Approved Essential Drugs For Nepal
by: No Author
Published: (2003-01-01) -
Repurposing of approved cardiovascular drugs
by: Ishida, Junichi, et al.
Published: (2016) -
New drug approvals in acute myeloid leukemia: what's the best end point?
by: Estey, E, et al.
Published: (2016) -
How Accurately Can We Predict the Melting Points of
Drug-like Compounds?
by: Tetko, Igor V., et al.
Published: (2014)